ACRS
Price
$1.93
Change
+$0.08 (+4.35%)
Updated
Aug 29, 03:42 PM (EDT)
Capitalization
199.33M
68 days until earnings call
XTNT
Price
$0.63
Change
-$0.00 (-0.00%)
Updated
Aug 29, 03:16 PM (EDT)
Capitalization
79.66M
62 days until earnings call
Interact to see
Advertisement

ACRS vs XTNT

Header iconACRS vs XTNT Comparison
Open Charts ACRS vs XTNTBanner chart's image
Aclaris Therapeutics
Price$1.93
Change+$0.08 (+4.35%)
Volume$440
Capitalization199.33M
Xtant Medical Holdings
Price$0.63
Change-$0.00 (-0.00%)
Volume$5K
Capitalization79.66M
ACRS vs XTNT Comparison Chart in %
Loading...
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRS vs. XTNT commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Buy and XTNT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (ACRS: $1.84 vs. XTNT: $0.63)
Brand notoriety: ACRS and XTNT are both not notable
ACRS represents the Biotechnology, while XTNT is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ACRS: 39% vs. XTNT: 88%
Market capitalization -- ACRS: $199.33M vs. XTNT: $79.66M
ACRS [@Biotechnology] is valued at $199.33M. XTNT’s [@Medical/Nursing Services] market capitalization is $79.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRS’s FA Score shows that 1 FA rating(s) are green whileXTNT’s FA Score has 0 green FA rating(s).

  • ACRS’s FA Score: 1 green, 4 red.
  • XTNT’s FA Score: 0 green, 5 red.
According to our system of comparison, ACRS is a better buy in the long-term than XTNT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRS’s TA Score shows that 4 TA indicator(s) are bullish while XTNT’s TA Score has 3 bullish TA indicator(s).

  • ACRS’s TA Score: 4 bullish, 4 bearish.
  • XTNT’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ACRS is a better buy in the short-term than XTNT.

Price Growth

ACRS (@Biotechnology) experienced а +5.14% price change this week, while XTNT (@Medical/Nursing Services) price change was +0.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.74%. For the same industry, the average monthly price growth was +15.52%, and the average quarterly price growth was +29.97%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.88%. For the same industry, the average monthly price growth was +6.74%, and the average quarterly price growth was +10.13%.

Reported Earning Dates

ACRS is expected to report earnings on Nov 05, 2025.

XTNT is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-0.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical/Nursing Services (+0.88% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACRS($199M) has a higher market cap than XTNT($79.7M). XTNT YTD gains are higher at: 42.212 vs. ACRS (-25.806). XTNT has higher annual earnings (EBITDA): 4.58M vs. ACRS (-57.87M). ACRS has more cash in the bank: 99.8M vs. XTNT (6.92M). XTNT has higher revenues than ACRS: XTNT (128M) vs ACRS (16.8M).
ACRSXTNTACRS / XTNT
Capitalization199M79.7M250%
EBITDA-57.87M4.58M-1,264%
Gain YTD-25.80642.212-61%
P/E RatioN/A69.24-
Revenue16.8M128M13%
Total Cash99.8M6.92M1,442%
Total DebtN/A37.1M-
FUNDAMENTALS RATINGS
ACRS vs XTNT: Fundamental Ratings
ACRS
XTNT
OUTLOOK RATING
1..100
1421
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4460
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACRS's Valuation (22) in the Pharmaceuticals Other industry is somewhat better than the same rating for XTNT (78) in the Medical Specialties industry. This means that ACRS’s stock grew somewhat faster than XTNT’s over the last 12 months.

ACRS's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as XTNT (100) in the Medical Specialties industry. This means that ACRS’s stock grew similarly to XTNT’s over the last 12 months.

ACRS's SMR Rating (100) in the Pharmaceuticals Other industry is in the same range as XTNT (100) in the Medical Specialties industry. This means that ACRS’s stock grew similarly to XTNT’s over the last 12 months.

ACRS's Price Growth Rating (44) in the Pharmaceuticals Other industry is in the same range as XTNT (60) in the Medical Specialties industry. This means that ACRS’s stock grew similarly to XTNT’s over the last 12 months.

ACRS's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as XTNT (100) in the Medical Specialties industry. This means that ACRS’s stock grew similarly to XTNT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACRSXTNT
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAJI0.12N/A
+0.73%
Marijuana Inc.
CVNZF0.46N/A
N/A
Comvita New Zealand Ltd.
JUMSF27.50N/A
N/A
Jumbo SA
HANOF3.05N/A
N/A
Hansen Technologies Ltd.
FUJIY11.99-0.06
-0.50%
FUJIFILM Holdings Corp.

ACRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with PLLWF. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then PLLWF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRS
1D Price
Change %
ACRS100%
+1.10%
PLLWF - ACRS
64%
Loosely correlated
N/A
MYNZ - ACRS
40%
Loosely correlated
+1.85%
UFPT - ACRS
39%
Loosely correlated
-1.53%
IBRX - ACRS
34%
Loosely correlated
-0.43%
ITRM - ACRS
34%
Loosely correlated
-4.16%
More

XTNT and

Correlation & Price change

A.I.dvisor tells us that XTNT and MEHCQ have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XTNT and MEHCQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTNT
1D Price
Change %
XTNT100%
+3.06%
MEHCQ - XTNT
25%
Poorly correlated
-0.79%
ACRS - XTNT
25%
Poorly correlated
+1.10%
MBOT - XTNT
24%
Poorly correlated
-1.72%
OM - XTNT
24%
Poorly correlated
-0.29%
QIPT - XTNT
23%
Poorly correlated
-0.75%
More